[图书][B] Pharmacology Research And Textbook 2: HIV-1 Integrase Inhibitors, Coenzyme Q10, and Ferroptosis
Page 1 Pharmacology Research And Textbook 2 Chapter1: HIV-1 Integrase Inhibitors and
Neurodevelopment Chapter2: Coenzyme Q10 Chapter3: Ferroptosis Author in Chief …
Neurodevelopment Chapter2: Coenzyme Q10 Chapter3: Ferroptosis Author in Chief …
HIV‐1 integrase inhibitors: 2005–2006 update
Abstract HIV‐1 integrase (IN) catalyzes the integration of proviral DNA into the host genome,
an essential step for viral replication. Inhibition of IN catalytic activity provides an attractive …
an essential step for viral replication. Inhibition of IN catalytic activity provides an attractive …
HIV-1 integrase inhibitors: a decade of research and two drugs in clinical trial
AA Johnson, C Marchand… - Current Topics in …, 2004 - ingentaconnect.com
AIDS is currently treated with a combination therapy of reverse transcriptase and protease
inhibitors. Recently, the FDA approved a drug targeting HIV-1 entry into cells. There are …
inhibitors. Recently, the FDA approved a drug targeting HIV-1 entry into cells. There are …
Novel integrase inhibitors for HIV
N Prada, M Markowitz - Expert Opinion on Investigational Drugs, 2010 - Taylor & Francis
Importance of the field: Integrase inhibitors are the newest class of antiretroviral agents
developed to treat HIV-1 infection. Raltegravir (RAL), the only integrase inhibitor (INI) …
developed to treat HIV-1 infection. Raltegravir (RAL), the only integrase inhibitor (INI) …
HIV-1 integrase inhibitors: an emerging clinical reality
R Dayam, LQ Al-Mawsawi, N Neamati - Drugs in R & D, 2007 - Springer
From the discovery of HIV-1 integrase (IN) inhibitors using enzyme-based assays in 1992, it
has taken 15 years to achieve success in human clinical trials. Currently available …
has taken 15 years to achieve success in human clinical trials. Currently available …
A historical sketch of the discovery and development of HIV-1 integrase inhibitors
A Savarino - Expert opinion on investigational drugs, 2006 - Taylor & Francis
The long process of HIV-1 integrase inhibitor discovery and development can be attributed
to both the complexity of HIV-1 integration and poor 'integration'of these researches into …
to both the complexity of HIV-1 integration and poor 'integration'of these researches into …
Targeting HIV-1 integrase.
K Sayasith, G Sauvé, J Yelle - Expert opinion on therapeutic targets, 2001 - europepmc.org
Human immunodeficiency virus Type 1 (HIV-1) integrase is an essential enzyme for the
obligatory integration of the viral DNA into the infected cell chromosome. As no cellular …
obligatory integration of the viral DNA into the infected cell chromosome. As no cellular …
[HTML][HTML] HIV integrase inhibitors—out of the pipeline and into the clinic
DV Havlir - New England Journal of Medicine, 2008 - Mass Medical Soc
Human immunodeficiency virus (HIV) infection has been transformed over the past two
decades from a fatal to a chronic disease, because of combination antiretroviral therapy—a …
decades from a fatal to a chronic disease, because of combination antiretroviral therapy—a …
HIV-1 integrase: from biology to chemotherapeutics
E Zeinalipour-Loizidou, C Nicolaou… - Current HIV …, 2007 - ingentaconnect.com
AIDS has claimed the lives of 25 million people worldwide, an additional 40 million people
are HIV-infected and new cases are being diagnosed every year. Despite the fact that …
are HIV-infected and new cases are being diagnosed every year. Despite the fact that …
New developments in diketo-containing inhibitors of HIV-1 integrase
G Zhao, C Wang, C Liu, H Lou - Mini Reviews in Medicinal …, 2007 - ingentaconnect.com
HIV-1 integrase is one of the three enzymes, which are critical for viral replication. It
catalyzes the integration of the HIV genome into the cellular chromosome. Since there is no …
catalyzes the integration of the HIV genome into the cellular chromosome. Since there is no …